Original Article
Original Article
/ VOLUME 6, ISSUE 3, SEPTEMBER 2024
Süreyya Damar-Örenler and others
Human immunodeficiency virus (HIV) remains a significant global health challenge with societal impacts. Despite a decline in the annual number of new cases worldwide, the incidence of HIV is on the rise in the Eastern Europe/Central Asia region, including Türkiye. With the introduction of new antiretroviral treatments (ARTs), HIV has transitioned from a […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Dilara Yıldırım and others
Tuberculosis (TB) is a common disease with high mortality and morbidity worldwide. Globally, an estimated 10.6 million people (95% uncertainty interval [UI]=9.9-11.4 million) developed TB in 2022, compared with 10.3 million in 2021 and 10.0 million in 2020. TB caused an estimated 1.30 million deaths worldwide in 2022 (95% UI=1.18-1.43 million). This was […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Khalis Mustafayev and others
Invasive Candida infections have increased significantly in recent years due to various risk factors, including invasive procedures, vascular catheterization, intra-abdominal surgery, prolonged use of broad-spectrum antibiotics, immunosuppressive medications, hemodialysis, total parenteral nutrition (TPN), and extended intensive care unit (ICU) stays. Candida, one of the top three nosocomial bloodstream infections, [...] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Muhammet Çağrı Yıldız and others
Real-time reverse transcriptase polymerase chain reaction (RT-PCR) is widely used to diagnose SARS-CoV-2. However, PCR tests need expensive equipment and qualified personnel, which makes them only used in high throughput and advanced laboratory settings. Improvements in SARS-CoV-2 diagnosis with easy, rapid, and cost-effective approaches […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Oruç Numan Gökçe and others
Cystic echinococcosis (CE), caused mainly by Echinococcus granulosus, is a parasitic disease common in Mediterranean countries such as Türkiye. Although it can occur anywhere in the body, it predominantly affects the liver. The disease is often asymptomatic; thus, cysts are often detected incidentally during imaging studies performed for other purposes. Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Melike İnan-Hekimoğlu and others
Cytomegalovirus (CMV) is a DNA virus from the Herpesviridae family that can remain latent in the body for life after primary infection and reactivate and cause viral shedding, especially in cases of immunosuppression. In studies conducted in different patient groups from Türkiye, CMV seroprevalence was reported to be between 85-100%. CMV can affect […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
İlker Devrim and others
The most common and serious complication of central venous catheter usage is central line–associated bloodstream infections (CLABSIs) in children and adults. Between 2011 and 2014, CLABSIs were the most frequently reported healthcare-associated illness among hospitals in the USA. Bloodstream infections associated with central lines are […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Sinan Çetin and Mediha Uğur
Clostridioides difficile is an anaerobic, Gram-positive, spore-forming bacteria found in the colon as part of the normal intestinal flora of a healthy individual. However, changes in the gut microbiota because of antibiotic use can lead to overgrowth of C. difficile and toxin […] Read More
Original Article
/ VOLUME 6, ISSUE 4, DECEMBER 2024
Fatihan Pınarlık and others
COVID-19 is caused by SARS-CoV-2 from the Coronaviridae family, Orthocoronaviridae sub family, Betacoronavirus genus, and Sarbecovirus subfamily (1). Cytokines and chemokines have been essential in the immune response against coronaviruses (2). First reports investigating clinical features of COVID-19 showed that serum levels of interleukin (IL)-2, IL-7, IL-10, granulocyte colony-stimulating factor (GSCF), IP10 (CXCL10), [...] Read More